Puma Biotechnology (PBYI) Short Interest Ratio & Short Volume → AI finds its first serious application (From Wall Street Star) (Ad) Free PBYI Stock Alerts $4.88 +0.05 (+1.04%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Puma Biotechnology Short Interest DataCurrent Short Volume3,330,000 sharesPrevious Short Volume3,290,000 sharesChange Vs. Previous Month+1.22%Dollar Volume Sold Short$17.82 millionShort Interest Ratio / Days to Cover5.9Last Record DateApril 15, 2024Outstanding Shares48,210,000 sharesFloat Size34,680,000 sharesShort Percent of Float9.60%Today's Trading Volume231,234 sharesAverage Trading Volume555,453 sharesToday's Volume Vs. Average42% Short Selling Puma Biotechnology ? Sign up to receive the latest short interest report for Puma Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPBYI Short Interest Over TimePBYI Days to Cover Over TimePBYI Percentage of Float Shorted Over Time Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Puma Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,330,000 shares $17.82 million +1.2%9.6%5.9 $5.35 3/31/20243,290,000 shares $17.44 million -1.2%9.5%5.4 $5.30 3/15/20243,330,000 shares $16.65 million -18.6%9.0%5.5 $5.00 2/29/20244,090,000 shares $25.44 million +13.9%11.0%7.8 $6.22 2/15/20243,590,000 shares $25.09 million +11.8%9.8%7.9 $6.99 1/31/20243,210,000 shares $15.09 million +6.3%8.7%9 $4.70 Get the Latest News and Ratings for PBYI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Puma Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,020,000 shares $14.95 million +4.1%8.1%9.4 $4.95 12/31/20232,900,000 shares $12.56 million +5.1%7.8%11.1 $4.33 12/15/20232,760,000 shares $10.82 million +35.3%7.4%12.4 $3.92 11/30/20232,040,000 shares $7.96 million +8.5%5.5%10.1 $3.90 11/15/20231,880,000 shares $7.14 million +9.3%5.1%11.1 $3.80 10/31/20231,720,000 shares $4.23 million -1.2%4.6%12 $2.46 10/15/20231,740,000 shares $4.11 million -0.6%4.7%13.5 $2.36 9/30/20231,750,000 shares $4.60 million +1.2%4.7%12.6 $2.63 9/15/20231,730,000 shares $5.29 million +3.6%4.7%10.4 $3.06 8/31/20231,670,000 shares $6.06 million +2.5%4.5%9.3 $3.63 8/15/20231,630,000 shares $5.85 million +0.6%4.1%8 $3.59 7/31/20231,620,000 shares $5.86 million -2.4%4.1%7.6 $3.62 7/15/20231,660,000 shares $5.53 million +3.8%4.3%7.8 $3.33 6/30/20231,600,000 shares $5.65 million +11.1%4.1%7.2 $3.53 6/15/20231,440,000 shares $5.11 million +5.9%3.7%5.9 $3.55 5/31/20231,360,000 shares $4.56 million No Change3.4%4.8 $3.35 5/15/20231,360,000 shares $4.00 million -1.5%3.4%4.5 $2.94 4/30/20231,380,000 shares $3.70 million +7.0%3.6%4.5 $2.68 4/15/20231,290,000 shares $3.90 million No Change3.3%4.1 $3.02 3/31/20231,290,000 shares $3.99 million +8.4%3.3%3.9 $3.09 3/15/20231,190,000 shares $2.88 million +3.5%3.1%3.4 $2.42 2/28/20231,150,000 shares $4.44 million +2.7%3.0%3.2 $3.86 2/15/20231,120,000 shares $4.76 million +6.7%3.0%3.1 $4.25 1/31/20231,050,000 shares $4.52 million +12.2%2.8%2.5 $4.30 1/15/2023935,800 shares $4.51 million +6.3%2.5%2.4 $4.82 12/30/2022880,500 shares $3.72 million -38.0%2.3%2.4 $4.23 12/15/20221,420,000 shares $6.97 million -5.3%3.7%4.4 $4.91 11/30/20221,500,000 shares $6.78 million +0.7%3.9%5.7 $4.52 11/15/20221,490,000 shares $5.07 million -2.0%3.9%6.4 $3.40 10/31/20221,520,000 shares $3.31 million No Change3.9%8.5 $2.18 10/15/20221,520,000 shares $3.39 million -5.0%3.9%8.2 $2.23 9/30/20221,600,000 shares $3.79 million -9.6%4.2%7.7 $2.37 9/15/20221,770,000 shares $4.53 million -2.2%4.6%5.8 $2.56 8/31/20221,810,000 shares $4.85 million -1.1%4.7%5.1 $2.68Thousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" PBYI Short Interest - Frequently Asked Questions What is Puma Biotechnology's current short interest? Short interest is the volume of Puma Biotechnology shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 3,330,000 shares of PBYI short. 9.60% of Puma Biotechnology's shares are currently sold short. Learn More on Puma Biotechnology's current short interest. What is a good short interest ratio for Puma Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PBYI shares currently have a short interest ratio of 6.0. Learn More on Puma Biotechnology's short interest ratio. Which institutional investors are shorting Puma Biotechnology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Puma Biotechnology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Puma Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.60% of Puma Biotechnology's floating shares are currently sold short. Is Puma Biotechnology's short interest increasing or decreasing? Puma Biotechnology saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 3,330,000 shares, an increase of 1.2% from the previous total of 3,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Puma Biotechnology's float size? Puma Biotechnology currently has issued a total of 48,210,000 shares. Some of Puma Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Puma Biotechnology currently has a public float of 34,680,000 shares. How does Puma Biotechnology's short interest compare to its competitors? 9.60% of Puma Biotechnology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Puma Biotechnology: XBiotech Inc. (3.40%), Xeris Biopharma Holdings, Inc. (6.37%), Verastem, Inc. (3.94%), 23andMe Holding Co. (10.48%), 2seventy bio, Inc. (13.60%), AC Immune SA (0.89%), Nektar Therapeutics (1.75%), Pyxis Oncology, Inc. (4.78%), Aldeyra Therapeutics, Inc (4.17%), Conduit Pharmaceuticals Inc. (0.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Puma Biotechnology stock? Short selling PBYI is an investing strategy that aims to generate trading profit from Puma Biotechnology as its price is falling. PBYI shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Puma Biotechnology? A short squeeze for Puma Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PBYI, which in turn drives the price of the stock up even further. How often is Puma Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBYI, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: XBiotech Short Squeeze Xeris Biopharma Short Squeeze Verastem Short Squeeze 23andMe Short Squeeze 2seventy bio Short Squeeze AC Immune Short Squeeze Nektar Therapeutics Short Squeeze Pyxis Oncology Short Squeeze Aldeyra Therapeutics Short Squeeze Conduit Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PBYI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press